Join 50,000+ High Performers Who've Discovered the NAD+ Advantage—More Energy, Sharper Focus, Faster Recovery.
Starting at $179
Your cellular powerhouse: NAD+ is the master molecule that fuels every cell in your body—driving energy production, DNA repair, inflammation control, and healthy metabolism. Think of it as your body's premium fuel that naturally depletes after age 30, dropping by half by middle age.
Why supplementation matters: When NAD+ levels crash, so does your vitality. Low NAD+ is directly linked to chronic fatigue, brain fog, poor recovery, and accelerated aging. Research confirms that boosting NAD+ can reverse these declines, restoring the cellular energy that keeps you performing at your peak.
Renuvia RX NAD+ therapy starts regular at just $347/month, including your medical consultation, prescription, medication, and free shipping. No hidden fees, no insurance hassles. Cancel hassle free, anytime. This is the most competitive pricing on the market.
After completing your medical intake, a Renuvia physician reviews your information within 2-4 hours. If approved, Renuvia sends your prescription to our pharmacy immediately. Most Renuvia patients receive their NAD+ within 3-5 business days with tracking information.
Renuvia's NAD+ therapy may help if you're experiencing low energy, brain fog, or signs of aging. Renuvia's board-certified physicians will review your medical history during your free consultation to ensure it's safe and appropriate for you. Most healthy adults 18+ qualify for Renuvia.
Many Renuvia patients report increased energy within the first 1-2 weeks. Mental clarity and focus often improve by week 3. Full benefits from Renuvia's NAD+ therapy typically develop over 4-8 weeks of consistent use.
NAD+ is naturally produced by your body and generally well-tolerated. Common side effects are mild. Our board-certified physicians review your complete medical history to ensure safety before prescribing.
Yes, NAD+ requires a prescription from a licensed physician. RenuviaRX's telehealth platform connects you with board-certified doctors who can prescribe NAD+ if medically appropriate. The consultation comes for FREE within our subscription package.
RenuviaRX NAD+ is administered via simple subcutaneous injection. RenuviaRX provides detailed video instructions and your kit includes everything needed. Most RenuviaRX patients master it in minutes!
You can cancel RenuviaRX anytime through your account or by emailing. No cancellation fees. RenuviaRX makes it easy to pause or cancel.
We analyzed 200+ peer-reviewed studies to bring you evidence-based NAD+ therapy. Here's what the research proves.
¹Ana P. Gomes et al., 'Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging', Cell, vol. 155, no. 7, 2013, pp. 1624-1638.
²Juliana Camacho-Pereira et al., 'CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism', Cell Metabolism, vol. 23, no. 6, 2016, pp. 1127-1139.
³Hassina Massudi et al., 'Age-Associated Changes in Oxidative Stress and NAD+ Metabolism in Human Tissue', PLOS One, vol. 7, no. 7, 2012, e42357.
Fei Yi et al., 'Association of Human Whole Blood NAD+ Contents With Aging', Frontiers in Endocrinology, vol. 13, 2022, article 829658.
⁵Jun Yoshino, Joseph A. Baur, and Shin-ichiro Imai, 'NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR', Cell Metabolism, vol. 27, no. 3, 2018, pp. 513-528.
⁶Michael S. Bonkowski and David A. Sinclair, 'Slowing Ageing by Design: The Rise of NAD+ and Sirtuin-Activating Compounds', Nature Reviews Molecular Cell Biology, vol. 17, no. 11, 2016, pp. 679-690.
⁷Anthony J. Covarrubias et al., 'Senescent Cells Promote Tissue NAD+ Decline During Ageing via the Activation of CD38+ Macrophages', Nature Metabolism, vol. 2, 2020, pp. 1265-1283.
⁸Michael R. McReynolds, Keir Chellappa, and Joseph A. Baur, 'Age-Related NAD+ Decline', Experimental Gerontology, vol. 134, 2020, article 110888.
⁹Nichola Conlon et al., 'The Use of a Systems Approach to Increase NAD+ in Human Participants', npj Aging, vol. 10, 2024, article 7.
¹⁰Christopher R. Martens et al., 'Chronic Nicotinamide Riboside Supplementation Is Well-Tolerated and Elevates NAD+ in Healthy Middle-Aged and Older Adults', Nature Communications, vol. 9, 2018, article 1286.